Raphael, A.; Kamm Feldman, A.; Lazarev, I.; Kian, W.; Peled, N.; Hod, K.; Shalata, W.; Dudnik, E.
Lung Immune Prognostic Index-Based Predictive Score in Advanced Non-Small Cell Lung Cancer with a Programmed Death Ligand-1 Tumor Proportion Score ≥ 50%. J. Clin. Med. 2025, 14, 3543.
https://doi.org/10.3390/jcm14103543
AMA Style
Raphael A, Kamm Feldman A, Lazarev I, Kian W, Peled N, Hod K, Shalata W, Dudnik E.
Lung Immune Prognostic Index-Based Predictive Score in Advanced Non-Small Cell Lung Cancer with a Programmed Death Ligand-1 Tumor Proportion Score ≥ 50%. Journal of Clinical Medicine. 2025; 14(10):3543.
https://doi.org/10.3390/jcm14103543
Chicago/Turabian Style
Raphael, Ari, Ayelet Kamm Feldman, Irina Lazarev, Waleed Kian, Nir Peled, Keren Hod, Walid Shalata, and Elizabeth Dudnik.
2025. "Lung Immune Prognostic Index-Based Predictive Score in Advanced Non-Small Cell Lung Cancer with a Programmed Death Ligand-1 Tumor Proportion Score ≥ 50%" Journal of Clinical Medicine 14, no. 10: 3543.
https://doi.org/10.3390/jcm14103543
APA Style
Raphael, A., Kamm Feldman, A., Lazarev, I., Kian, W., Peled, N., Hod, K., Shalata, W., & Dudnik, E.
(2025). Lung Immune Prognostic Index-Based Predictive Score in Advanced Non-Small Cell Lung Cancer with a Programmed Death Ligand-1 Tumor Proportion Score ≥ 50%. Journal of Clinical Medicine, 14(10), 3543.
https://doi.org/10.3390/jcm14103543
